Cooperative Agreement IDSEP230067

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

This Cooperative Agreement award of $4,603,542, provided by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750), aims to assess domestic production of pharmaceutical products for the U.S. Military Health System. The award was made on November 7, 2024 with a completion date of November 6, 2026. The key products/services to be delivered include: Developing primers on "make-buy-invest" strategic...

This $595,834 cooperative agreement award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a Phase 1 safety trial for TRL1068, an inhaled therapeutic antibody treatment developed by Trellis Bioscience, Inc. to target bacterial pneumonia. The funding will enable the company to conduct clinical testing of this novel antibody-based intervention, which has shown promise in disrupting bacterial...

The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. will provide biomarker reference laboratory services under a $475,449 cooperative agreement awarded by the Uniformed Services University of the Health Sciences on September 6, 2022. The award will support the operation of the Early Detection Research Network Biomarker Reference Laboratory at the Center for Prostate Disease Research through August 31, 2023. The laboratory performs validation studies and provides...

This Cooperative Agreement award from the Uniformed Services University of Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750) provides $1,853,685.00 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to support the development of a broad-spectrum combination antibacterial therapy with a metallo beta-lactamase inhibitor against multi-drug resistant (MDR) wound infections. The project aims to advance medical...

This Cooperative Agreement award, with a total funding of $677,322.00, was granted by the Uniformed Services University of Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750). The award supports research to define the functionality of virus-specific effector T cells and B cells in a preclinical BSL-2 mouse model of Henipavirus infection. The project aims to improve understanding of the immune response to these viral pathogens, which is critical...

The federal Cooperative Agreement award, with the ID HU00012420038, provides $111,150.00 to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF) to study the roles of amphiregulin in multi-organs of mice exposed to partial body irradiation. The award is funded through the Uniformed Services University Medical Research Projects program (CFDA 12.750), administered by the Uniformed Services University of the Health Sciences, a DOD agency. This research project aims...

This Cooperative Agreement award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to the Virginia Biotechnology Research Park Corporation (dba Activation Capital) to develop a robust pharmaceutical cluster program called the Alliance for Building Better Medicine in the Richmond/Petersburg region of Virginia. Over an 18-month period, the awardee will work with 23 core partners, including three direct...

The Uniformed Services University of the Health Sciences awarded a $2,519,513 Cooperative Agreement to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Uniformed Services University Medical Research Projects program (CFDA 12.750). This award, with a period of performance from April 1, 2025 to March 31, 2028, will support the development of a Bunyavirus survivor cohort to discover biological countermeasures. The Henry M. Jackson Foundation, a non-profit...

This $2,392,831 Cooperative Agreement was awarded by the Uniformed Services University of Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750) to support the Infectious Disease Clinical Research Program (IDCRP) Defense Health Program (DHP) FY24 CORE. The award has a period of performance from July 1, 2024 to June 30, 2025. The prime awardee is The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit...